Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 52, 3361-3366, June 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De La Rosa, J.
Right arrow Articles by Kotb, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De La Rosa, J.
Right arrow Articles by Kotb, M.

Induction of Interleukin 2 Production but not Methionine Adenosyltransferase Activity or S-Adenosylmethionine Turnover in Jurkat T-Cells1

James De La Rosa, Arthur M. Geller, H. Leighton LeGros, Jr. and Malak Kotb2

Veterans Administration Medical Center, Research Service, Memphis, Tennessee 38104 [J. D. L. R., H. L. L., M. K.]; and the Departments of Surgery, Microbiology, and Immunology [J. D. L. R., M. K.] and Biochemistry [A. M. G.], University of Tennessee, Memphis, Tennessee 38163

We have recently reported that methionine adenosyltransferase (MAT) in resting human peripheral blood T-cells is primarily present in the form of a precursor which we named {lambda}. This protein decreases upon cell stimulation, as both MAT activity and the amount of the catalytic {alpha}/{alpha}' subunits of the enzyme increase. When resting cells are activated by phytohemagglutinin, the decrease in {lambda} and increase in {alpha}/{alpha}' occurs after interleukin 2 (IL-2) production and before DNA synthesis. The human T-leukemia cell line, Jurkat, is unique in its ability to produce IL-2 in response to exogenous stimuli such as T-cell mitogens and therefore provides a convenient model for studying biochemical reactions involved in T-cell activation. In this study the regulation of MAT activity and S-adenosylmethionine (AdoMet) in resting and activated Jurkat cells was investigated. Here we report that MAT activity in unstimulated Jurkat cells is about 10- and 3-fold higher than the activity in resting and activated peripheral blood mononuclear cells, respectively. Activation of Jurkat cells with phytohemagglutinin resulted in increased IL-2 production, but not an increase in MAT activity. Identical results were obtained using freshly isolated cells from acute lymphoblastic leukemia patients. AdoMet utilization and pool size were approximately 3- and 10-fold higher, respectively, in Jurkat cells compared to peripheral blood mononuclear cells, and both parameters were unaffected by phytohemagglutinin stimulation. Jurkat MAT was determined to be structurally indistinguishable from enzyme from T- or B-leukemia cells but was different from resting, normal T-cells in that it lacked the {lambda} form. Furthermore, unlike MAT in resting T-cells, the relative amounts of the {alpha}, {alpha}', and ß subunits of the enzyme did not change throughout the course of IL-2 induction. We conclude that AdoMet metabolism and MAT activity in Jurkat cells are constitutively high and that induction of IL-2 synthesis in these cells is independent of changes in AdoMet synthesis or turnover. The lack of the {lambda} form and the difference in MAT regulation between leukemic T-cells and peripheral blood mononuclear cells may be exploited in the design of specific chemotherapeutic agents.

1 This work was supported in part by grants from the United States Veterans Administration (M. K.), and from the NIH, GM-38530 (M. K.). The ALL-2 cells were obtained from The Leukemia Cell Bank (LCB) at St. Jude's Children's Research Hospital with the assistance of Dr. Fredrick Behm. The LCB is supported by the National Cancer Institute and by funds from the American Lebanese and Syrian Associated Charities.

2 To whom requests for reprints should be addressed, at the V. A. Medical Center (151), 1030 Jefferson Ave., Memphis, TN 38104.

Received 11/20/91. Accepted 4/ 7/92.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H L. LeGros Jr., A. M. Geller, and M. Kotb
Differential Regulation of Methionine Adenosyltransferase in Superantigen and Mitogen Stimulated Human T Lymphocytes
J. Biol. Chem., June 20, 1997; 272(25): 16040 - 16047.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. De La Rosa, J. Ostrowski, M. M. Hryniewicz, N. M. Kredich, M. Kotb, H. L. LeGros Jr., M. Valentine, and A. M. Geller
Chromosomal Localization and Catalytic Properties of the Recombinant alpha Subunit of Human Lymphocyte Methionine Adenosyltransferase
J. Biol. Chem., September 15, 1995; 270(37): 21860 - 21868.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-B. Halim, L. LeGros, M. E. Chamberlin, A. Geller, and M. Kotb
Regulation of the Human MAT2A Gene Encoding the Catalytic alpha 2 Subunit of Methionine Adenosyltransferase, MAT II. GENE ORGANIZATION, PROMOTER CHARACTERIZATION, AND IDENTIFICATION OF A SITE IN THE PROXIMAL PROMOTER THAT IS ESSENTIAL FOR ITS ACTIVITY
J. Biol. Chem., March 23, 2001; 276(13): 9784 - 9791.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. LeGros, A.-B. Halim, M. E. Chamberlin, A. Geller, and M. Kotb
Regulation of the Human MAT2B Gene Encoding the Regulatory beta Subunit of Methionine Adenosyltransferase, MAT II
J. Biol. Chem., June 29, 2001; 276(27): 24918 - 24924.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1992 by the American Association for Cancer Research.